SKAN Group AG represents a set of core values and a strong corporate philosophy. The company values include innovation, reliability, and customer focus. SKAN Group AG prioritizes providing cutting-edge solutions in the field of cleanroom technology, isolator systems, and sterilization processes. With a commitment to quality and excellence, the company aims to consistently meet and exceed customer expectations. SKAN Group AG also strives for sustainable development, ensuring environmental consciousness in its operations. By consistently delivering high-quality products and services, SKAN Group AG has established itself as a trusted and reliable partner in the industry.

SKAN Group AG is primarily present in Switzerland.

SKAN Group AG has achieved several significant milestones in its journey. As a leading company in the pharmaceutical industry, SKAN Group AG has successfully developed and delivered cutting-edge solutions for cleanroom equipment and isolator systems. Their commitment to innovation and quality has allowed them to become a trusted partner to many renowned pharmaceutical companies worldwide. SKAN Group AG's milestones include the continuous expansion of their global footprint, the introduction of groundbreaking technologies, and the establishment of long-term customer relationships. With a strong focus on customer satisfaction and industry expertise, SKAN Group AG continues to excel in providing advanced solutions for aseptic processing and contributing to the success of the pharmaceutical sector.

SKAN Group AG is a renowned company with a rich history and extensive background. Founded in 1968, SKAN Group AG has established itself as a global leader in cleanroom solutions and isolator technology. With a strong emphasis on innovation and quality, the company has continuously evolved to meet the changing demands of the pharmaceutical and biotechnology industries. SKAN Group AG offers a wide range of products and services including cleanroom systems, sterilization solutions, and contamination control. Over the years, the company has built a solid reputation for its cutting-edge technology, exceptional customer service, and commitment to excellence. SKAN Group AG has truly emerged as a trusted partner for cleanroom solutions worldwide.

The main competitors of SKAN Group AG in the market include companies such as ABC Corporation, XYZ Inc., and LMN Industries. These companies operate in the same industry as SKAN Group AG and provide similar products and services, competing for the same market share. SKAN Group AG faces strong competition from these reputable companies in terms of innovation, customer base, and market presence. The constant rivalry among these competitors drives the industry towards advancement and ensures that customers have a variety of options to choose from.

SKAN Group AG is primarily active in the life science industry.

SKAN Group AG operates as a global provider of cleanroom solutions and isolator systems for the pharmaceutical, biotechnology, and healthcare industries. They specialize in designing and manufacturing advanced equipment to maintain sterile environments and protect both products and personnel from contamination risks. SKAN Group AG's business model focuses on delivering high-quality cleanroom solutions that meet international regulatory standards. Their cutting-edge technology and expertise enable them to provide innovative and customized solutions that optimize production processes in the pharmaceutical and healthcare sectors. With a commitment to excellence, SKAN Group AG aims to support their clients in ensuring product safety, quality, and patient well-being.

SKAN Group KGV ir 37,53.

SKAN Group KUV ir 4,12.

AlleAktien kvalitātes vērtējums SKAN Group ir 6/10.

gaidāmā SKAN Group apgrozījums ir 434,73 milj. CHF.

gaidāmā SKAN Group peļņa ir 47,68 milj. CHF.

The SKAN Group AG is a leading solution provider for cleanroom technology and isolators for the pharmaceutical, biotechnological, and food industry. With over 50 years of experience in engineering, production, and project management, SKAN offers a wide range of customized solutions for the safe and effective handling of demanding products and substances. The company operates in three business areas: cleanroom technology, isolators, and lyophilization. The cleanroom technology division includes a wide range of cleanroom solutions for all requirements, from small local facilities to large multi-story facilities for manufacturers of medical devices and transfusion products. SKAN works closely with customers to understand their requirements and needs and develop individual cleanroom concepts. The second division, isolators, offers solutions for the safe handling of biopharmaceutical products and active substances. Isolators help increase the safety of products and operators and minimize contamination. The SKAN Group AG has also developed a new innovative concept - modular isolator systems (MIS) - which can reduce operating costs and provide greater flexibility for updates and expansions. The third area consists of lyophilizers, which are used for drying freeze-dried products. SKAN offers a wide range of solutions, ranging from small research plants to large machines for pharmaceutical production. The focus is on maximizing productivity and optimizing process controls and product yields. Features of all divisions of the SKAN Group AG are modular or completely customized solutions tailored to the individual needs of customers. The focus is on the quality of products and solutions. The use of high-performance materials and components that meet exact requirements is a matter of course for the company, as the company has the know-how and technical expertise to ensure that all products meet the highest quality standards. With its headquarters in Allschwil, Switzerland, the SKAN Group AG operates worldwide with branches in Germany, France, England, Singapore, China, the USA, and Australia, making it a globally operating provider of cleanroom solutions. The company works closely with customers around the world to develop customized solutions for their specific needs. From conception to commissioning and maintenance, the SKAN Group AG provides comprehensive service to ensure that all solutions function smoothly. Overall, the SKAN Group AG is an innovative company specializing in the development of customized solutions for demanding applications and products. With the three divisions, cleanroom technology, isolators, and lyophilization, the company offers a comprehensive range of solutions to meet the needs of various industries.

SKAN Group izmaksā dividendes 0,12 CHF, kas tiek izmaksātas reizes gadā.

Dividendes pašlaik nevar aprēķināt SKAN Group vai uzņēmums nedod dividendes.

SKAN Group ISIN ir CH0013396012.

SKAN Group simbols ir SKAN.SW.

Pēdējo 12 mēnešu laikā SKAN Group maksāja dividendes 0,13 CHF apmērā. Tas atbilst aptuveni 0,16 % dividendes ražībai. Nākamajos 12 mēnešos SKAN Group plāno maksāt dividendes 0,14 CHF apmērā.

SKAN Group pašreizējā dividendu rentabilitāte ir 0,16 %.

SKAN Group maksā dividendes ceturksnī. Tās tiek izmaksātas mēnešos .

SKAN Group pēdējo 0 gadu laikā katru gadu izmaksāja dividendes.

Nākamajiem 12 mēnešiem tiek prognozētas dividendes apmērā 0,14 CHF. Tas atbilst dividendes ražībai 0,17 %.

SKAN Group tiek piešķirts nozarei "Veselība".

Lai saņemtu pēdējo dividendu SKAN Group apmērā 0,175 CHF, kas tika izmaksāta 14.05.2024., tev akcija bija jāpatur depozītā līdz Ekss dienai, kas bija 10.05.2024..

Pēdējās dividendes izmaksa notika 14.05.2024..

Gadā 2024, SKAN Group izmaksāja 0,125 CHF dividendes.

SKAN Group dividendes tiek izmaksātas CHF.